1. Home
  2. BG vs ILMN Comparison

BG vs ILMN Comparison

Compare BG & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bunge Limited

BG

Bunge Limited

HOLD

Current Price

$124.51

Market Cap

24.1B

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$122.55

Market Cap

20.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BG
ILMN
Founded
1818
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.1B
20.4B
IPO Year
2023
2000

Fundamental Metrics

Financial Performance
Metric
BG
ILMN
Price
$124.51
$122.55
Analyst Decision
Strong Buy
Hold
Analyst Count
7
17
Target Price
$130.29
$124.24
AVG Volume (30 Days)
1.5M
1.8M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
2.22%
N/A
EPS Growth
N/A
170.87
EPS
4.91
5.45
Revenue
$70,329,000,000.00
$4,343,000,000.00
Revenue This Year
$34.76
$6.52
Revenue Next Year
$1.62
$5.49
P/E Ratio
$25.77
$22.20
Revenue Growth
32.43
N/A
52 Week Low
$71.60
$68.70
52 Week High
$128.46
$155.53

Technical Indicators

Market Signals
Indicator
BG
ILMN
Relative Strength Index (RSI) 60.56 46.25
Support Level $111.01 $114.88
Resistance Level $124.78 $135.68
Average True Range (ATR) 3.56 4.25
MACD 0.23 0.03
Stochastic Oscillator 76.40 37.31

Price Performance

Historical Comparison
BG
ILMN

About BG Bunge Limited

Bunge Global SA is an agribusiness solutions company, connecting farmers to consumers and delivering essential food, feed and fuel to the globe. The company segments include Soybean Processing and Refining; Softseed Processing and Refining; Other Oilseeds Processing and Refining; Grain Merchandising and Milling; and Corporate and Other. It generates maximum revenue from the Soybean Processing and Refining segment, which includes integrated business principally involved in the purchase, storage, transportation, processing, distribution, refining, marketing, and sale of soybeans and soybean related products, as well as biodiesel and fertilizer production and distribution. Geographically, the company operates in United States, Switzerland, Netherlands, and Rest of the World.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: